Generic Drug Review: US FDA Approves More ANDAs Than It Receives For First Time Since Early 2016
Executive Summary
Among the 61 approvals in February appear to be ANDAs from the official GDUFA backlog, which have been pending for more than four years.
You may also be interested in...
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
Generic Drug Puzzle: Why Did ANDA Submissions Spike Again?
Jump in March may have been "happenstance," but also could be concerning as US ANDA submissions reach near record pace.